News | April 29, 2025
Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
We have big plans across our B2C and B2B businesses in India and abroad
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Subscribe To Our Newsletter & Stay Updated
